At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
Intravitreal injection siteprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Entry Site Distance From Limbus on Perceived Pain During Intravitreal Injection of Anti-VEGF (Vascular Endothelial Growth Factor) Agents
The University of Texas Medical Branch, Galveston·observational·Posted Dec 7, 2022·Updated Jan 31, 2025
In Brief
An observational study evaluating Intravitreal injection site for Pain. Completed, enrolled 53 participants across 1 site.
Detailed Summary
The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartNov 2022
First PostedDec 2022
Primary CompletionDec 2023
Study CompletionSep 2024
TodayJul 2026
First PostedDec 7, 2022
Enrollment StartNov 14, 2022
Primary CompletionDec 18, 2023
Study CompletionSep 9, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.6 years ago
Interventions
Intravitreal injection siteprocedure
Intravitreal injections will be made at varying sites; patients will report on pain perception